Inovio Pharmaceuticals is a biotechnology company focused on developing innovative therapies and vaccines for the treatment of serious diseases, particularly cancers and infectious diseases

Utilizing its proprietary DNA medicines platform, Inovio is engaged in creating synthetic DNA-based therapies that aim to trigger an immune response in the body to fight off disease. The company is dedicated to advancing its product candidates through various phases of clinical trials, and it collaborates with various organizations and institutions to enhance its research and development efforts, ultimately striving to address unmet medical needs and improve patient outcomes.